These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17507865)

  • 41. A crucial role of RORγt in the development of spontaneous Sialadenitis-like Sjögren's syndrome.
    Iizuka M; Tsuboi H; Matsuo N; Asashima H; Hirota T; Kondo Y; Iwakura Y; Takahashi S; Matsumoto I; Sumida T
    J Immunol; 2015 Jan; 194(1):56-67. PubMed ID: 25411202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diversity of regulatory T cells to control arthritis.
    van Roon JA; Bijlsma JW; Lafeber FP
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):897-913. PubMed ID: 16980213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy.
    Bayry J; Sibéril S; Triebel F; Tough DF; Kaveri SV
    Drug Discov Today; 2007 Jul; 12(13-14):548-52. PubMed ID: 17631249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of soluble programmed death-1 protein in peripheral blood regulatory T cells and its effects on rheumatoid arthritis progression.
    Ren CF; Zhao YX; Hou CF; Luan L; Duan GQ; Li SJ; Zhao JH
    Mol Med Rep; 2017 Jan; 15(1):460-466. PubMed ID: 27909722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory T cells in systemic lupus erythematosus.
    Ohl K; Tenbrock K
    Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
    Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
    J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of regulatory T cells in systemic lupus erythematosus.
    Gerli R; Nocentini G; Alunno A; Bocci EB; Bianchini R; Bistoni O; Riccardi C
    Autoimmun Rev; 2009 Mar; 8(5):426-30. PubMed ID: 19185065
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulatory T cells in lupus.
    Kang HK; Datta SK
    Int Rev Immunol; 2006; 25(1-2):5-25. PubMed ID: 16531276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulatory T Cells in SLE: Biology and Use in Treatment.
    Giang S; La Cava A
    Curr Rheumatol Rep; 2016 Nov; 18(11):67. PubMed ID: 27704250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
    Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
    PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.
    Yurchenko E; Levings MK; Piccirillo CA
    Eur J Immunol; 2011 Dec; 41(12):3455-66. PubMed ID: 21956668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
    Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
    J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.
    Bashi T; Blank M; Ben-Ami Shor D; Fridkin M; Versini M; Gendelman O; Volkov A; Barshak I; Shoenfeld Y
    J Autoimmun; 2015 May; 59():1-7. PubMed ID: 25864802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In Vivo Induction of Functionally Suppressive Induced Regulatory T Cells from CD4+CD25- T Cells Using an Hsp70 Peptide.
    van Herwijnen MJ; van der Zee R; van Eden W; Broere F
    PLoS One; 2015; 10(6):e0128373. PubMed ID: 26107957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Regulatory T cells and their influence in kidney allograft survival].
    Velásquez SY; García LF; Alvarez CM
    Medicina (B Aires); 2007; 67(5):491-501. PubMed ID: 18051235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory T cells in immune-mediated renal disease.
    Ghali JR; Wang YM; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2016 Feb; 21(2):86-96. PubMed ID: 26206106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural and induced T CD4+CD25+FOXP3+ regulatory T cells.
    Chatenoud L
    Methods Mol Biol; 2011; 677():3-13. PubMed ID: 20941599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.